Fluoxetine

Fluoxetine is an FDA-approved medication that has demonstrated efficacy in treating a spectrum of psychological conditions. These indications include major depressive disorder, obsessive-compulsive disorder, panic disorder, bulimia, binge eating disorder, premenstrual dysphoric disorder, and bipolar depression, including cases of treatment-resistant depression when combined with olanzapine. The mechanism of action involves the inhibition of serotonin reuptake in presynaptic neurons, achieved by blocking the reuptake transporter protein. This activity provides insights into fluoxetine's indications, off-label uses, mechanism of action, dosing, adverse effects, contraindications, monitoring, and toxicity.

Copyright © 2024, StatPearls Publishing LLC.

Conflict of interest statement

Disclosure: Ahsan Sohel declares no relevant financial relationships with ineligible companies.

Disclosure: Mollie Shutter declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

Disclosure: Mohammed Molla declares no relevant financial relationships with ineligible companies.

Sections

Similar articles

Maher AR, Theodore G. Maher AR, et al. J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.s5-b.1. J Manag Care Pharm. 2012. PMID: 22784311 Free PMC article. Review.

Sharbaf Shoar N, Fariba KA, Padhy RK. Sharbaf Shoar N, et al. 2023 Nov 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Nov 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489221 Free Books & Documents.

Schwasinger-Schmidt TE, Macaluso M. Schwasinger-Schmidt TE, et al. Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167. Handb Exp Pharmacol. 2019. PMID: 30194544

Masand PS, Gupta S. Masand PS, et al. Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84. Harv Rev Psychiatry. 1999. PMID: 10471245 Review.

Singh HK, Saadabadi A. Singh HK, et al. 2023 Feb 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Feb 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31613469 Free Books & Documents.

References

    1. Mikocka-Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, Andrews JM. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2019 Apr 12;4(4):CD012680. - PMC - PubMed
    1. Dhenain T, Côté F, Coman T. Serotonin and orthodontic tooth movement. Biochimie. 2019 Jun;161:73-79. - PubMed
    1. Burch R. Antidepressants for Preventive Treatment of Migraine. Curr Treat Options Neurol. 2019 Mar 21;21(4):18. - PubMed
    1. Crone C, Fochtmann LJ, Attia E, Boland R, Escobar J, Fornari V, Golden N, Guarda A, Jackson-Triche M, Manzo L, Mascolo M, Pierce K, Riddle M, Seritan A, Uniacke B, Zucker N, Yager J, Craig TJ, Hong SH, Medicus J. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders. Am J Psychiatry. 2023 Feb 01;180(2):167-171. - PubMed
    1. Li X, Li J, Li X, Wang J, Dai H, Wang J. Effectiveness and safety of fluoxetine for premature ejaculation: Protocol for a systematic review. Medicine (Baltimore) 2019 Feb;98(7):e14481. - PMC - PubMed